Camber launches generic Reyata

Print Friendly, PDF & Email

PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of atazanavir capsules to their current portfolio.

Atazanavir capsules are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients 6 years and older weighing at least 33 lbs.

Atazanavir capsules from Camber are available in 150 mg and 200 mg- 60 count bottles and 300 mg- 30 count bottle.



Comments are closed.